Moreover, previous consideration of NMDA receptor antagonism as potential treatment for binge-eating disorder suggests that the weight-lowering benefits linked to GLP-1MK-801 could be the result of a combined impact on both energy homeostasis and disordered eating behaviours 10,14,41
A role for glucagon-like peptide-1 in the central regulation of feeding [see comments]
In obesity studies, it increased fat burning and blood glycerol levels (a marker of fat breakdown) and reduced body weight, without affecting blood sugar control
An increased incidence of micronuclei was observed after one intraperitoneal dose of 100 mg/kg body weight in mice (Lyarskii et al., 1983) and after 4 h of vapour exposure of rats to a concentration of 90 mg/m 3 (Embree & Hine, 1975)
Do not administer another dose until you receive professional guidance
Some individuals lose less than 5% of their body weight, whereas others lose more than 20%